AU · Healthcare

Neurizon Therapeutics Ltd (NUZ)

Diversified

Neurizon Therapeutics Ltd (NUZ) is listed on AU in the Healthcare sector. Industry: Diversified. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NUZ

P/E ratio

18.00

Neurizon Therapeutics Ltd (NUZ) — FAQ

What is NUZ's P/E ratio?

The price-to-earnings (P/E) ratio for Neurizon Therapeutics Ltd (NUZ) is 18.00 (data as of 2026-05-24).

Does Neurizon Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Neurizon Therapeutics Ltd (NUZ). Check the MyAverix Finance app for the latest dividend data.

What sector is Neurizon Therapeutics Ltd in?

Neurizon Therapeutics Ltd (NUZ) is classified in the Healthcare sector (Diversified industry).

What exchange is NUZ listed on?

NUZ is listed on AU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)